Skip to main navigation
Neurogene Therapeutics
Contact Us
  • ABOUT US
  • TECHNOLOGY
  • PIPELINE
  • PATIENTS AND FAMILIES
  • INVESTORS
  • CAREERS
  • CONTACT US
  • TWITTER
  • LINKEDIN
  • FACEBOOK
  • Overview
  • News & Events
    • News Releases
    • Events & Presentations
  • Corporate Governance
    • Governance Overview
    • Leadership Team
    • Board of Directors
    • Committee Composition
  • Financial Information
    • SEC Filings
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Shareholder Services
    • Investor FAQs
    • Email Alerts
    • RSS Feeds
    • Investor Contacts

Events & Presentations

  • Overview
  • News & Events
    • News Releases
    • Events & Presentations
  • Corporate Governance
    • Governance Overview
    • Leadership Team
    • Board of Directors
    • Committee Composition
  • Financial Information
    • SEC Filings
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Shareholder Services
    • Investor FAQs
    • Email Alerts
    • RSS Feeds
    • Investor Contacts

Past Events

Nov 19, 2024 12:40 PM EST
Stifel 2024 Healthcare Conference
Link to Webcast
Nov 11, 2024 4:30 PM EST
NGN-401 Interim Clinical Data Webcast
Link to Webcast

Presentations

CNS 2024 - NGN-401 Interim Clinical Data Poster 396.5 KB
Nov 2024 - NGN-401 Interim Clinical Data Presentation 2 MB
IRSF 2024 - Clinical Safety Poster 715.2 KB
ASGCT 2024 - NGN-401 Clinical Safety Poster 550 KB
ASGCT 2023 - Comparison and Characterization of AAV9 Product from Baculovirus and HEK293 Processes 821.4 KB
Neurogene Inc.

Corporate Headquarters
535 W 24th Street, 5th Floor
New York, NY 10011

Manufacturing Headquarters
Houston, TX 77025
 

© 2025 Neurogene Inc.
GL-GEN-WEB-0002v8

Contact Us
Translation Disclaimer
  • Privacy
  • Terms of Use